DOWNERS GROVE, IL / ACCESS Newswire / October 8, 2025 / Duly Health and Care, through its Chicagoland medical group, DuPage Medical Group, LTD., is now offering access to the Galleri® multi-cancer ...

By: Gretchen Stipec, M.D., radiologist, Cancer Institute, Long Beach Medical Center Seniors account for nearly 28% of all new ...

Samsung C&T and Samsung Electronics Will Make an Equity Investment of $110 Million Into GRAIL, Subject to Closing Conditions "Guided by its commitment to advancing next-generation bio-technologies and ...

MENLO PARK, Calif., Oct. 17, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that positive ...

One-Third of Participants Initially Believed to Have a False-Positive Result Were Later Diagnosed With Cancer During Follow Up Updated Positive Predictive Value of Galleri in This Symptomatic ...

New data will help bolster Grail’s PMA submission to FDA for Galleri, a multi-cancer early detection test. The data in question is the Menlo Park, CA-based company’s positive top-line performance and ...

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings from the PATHFINDER study of ...

Using a single blood sample, multi-cancer early detection (MCED) tests screen for numerous types of cancers, including breast, ovarian, colorectal, pancreatic and prostate cancers. Trials are underway ...

SEOUL, Korea and MENLO PARK, Calif., Oct. 16, 2025 /PRNewswire/ -- Samsung C&T (SCT), Samsung Electronics (SEC), and GRAIL, Inc. (Nasdaq: GRAL), today announced they have signed a binding Letter of ...

"Guided by its commitment to advancing next-generation bio-technologies and improving quality of life, Samsung C&T has continuously invested in innovative companies. The collaboration with GRAIL ...